SPY422.11-2.37 -0.56%
DIA340.76-2.65 -0.77%
IXIC14,039.68-33.17 -0.24%

Significant Insider Selling in Shares of Charles River Labs International (CRL) Continues

05/10/2021 18:25

10:20 PM EDT, 05/10/2021 (MT Newswires) -- One insider -- George Massaro, Director -- today, disposed of 3,370 shares of Charles River Labs International having a market value of approximately $1,135,561, as disclosed in a form 4 document filed with the SEC. There have been 2 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the disposition of 32,000 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 35,370 shares and have averaged 11,790 shares per transaction over this time period.

The number of insider buy/sell trades at Charles River Labs International is greater than that of the 207 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 270 buy/sell trades during this period for an average of 1.3 transactions per company. However, the number of shares traded per transaction by Charles River Labs International insiders is lower than its peers. Within the peer group there were 102,899,632 shares purchased and 23,863,270 shares sold with company insiders purchasing 479,008 shares on average over this time period.

The data sourced in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

[Disclaimer]
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.